Fabian Pottbäcker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fabian Pottbäcker has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alexander M Zenner
Digital Health Center Hasso Plattner Institute for Digital Engineering University of Potsdam Potsdam Germany
2 shared publications - Babajide Owoyele
Artificial Intelligence and Intelligent Systems Hasso Plattner Institute Potsdam Potsdam Germany
2 shared publications - Darius Ferenc Ruether
Charité – University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
2 shared publications - Eddye Golden
Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, United States
2 shared publications - Erwin P. Bottinger
Digital Health Center Hasso Plattner Institute University of Potsdam Potsdam Germany
2 shared publications - Florian Henschel
Digital Health Center Hasso Plattner Institute for Digital Engineering University of Potsdam Potsdam Germany
2 shared publications
Latest Publications
- Open Access
- 5 July 2022
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 24 (7) , e35884
StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.
- 5 July 2022
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 24 (7) , e35884
Open AccessStudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials
N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.
- Open Access
- 21 December 2021
- Published by JMIR Publications Inc. in JMIR Preprints
StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials (Preprint)
UNSTRUCTURED N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.
- 21 December 2021
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessStudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials (Preprint)
UNSTRUCTURED N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully functional platforms are not yet available. Here, we present the open source StudyU platform, which includes the StudyU Designer and StudyU app. With the StudyU Designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone app with innovative user-centric elements for participants to partake in trials published through the StudyU Designer to assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.